Modular Closed Cell Culture for Scalable T-Cell Manufacturing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for isolating, preparing, and expanding cancer antigen-specific T-cells are labor-intensive, prone to contamination, and not scalable, failing to meet current good manufacturing practices (cGMP) for large-scale T cell therapy production.
Innovation Solution
Automated cell culture systems with interchangeable cartridges and closed systems for producing antigen-specific T cells, using polystyrene surfaces for cell adhesion and sterile tube welding, enabling parallel processing and recycling of cell culture medium to minimize contamination and user error.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If manual protocols are used for T cell isolation, preparation, and expansion, then flexibility in protocol customization is maintained, but labor intensity increases and scalability is limited
Solution Approach 1:
The system divides the cell culture process into separate functional modules (incubation module, stimulation module, expansion module) that can be independently configured and operated. Each module handles a specific aspect of T cell processing, allowing parallel processing of multiple cell types while maintaining protocol flexibility through modular assembly.
Solution Approach 2:
The automated cell culture system is designed with universal components that can handle multiple cell types (T cells, dendritic cells, CAR-T cells) and various culture conditions. The system uses standardized interfaces and reusable modules that can be reconfigured for different protocols, maintaining flexibility while enabling high-throughput processing.
2Ease of operation
If flasks or containers are opened and closed during cell culture operations, then manual access for media changes and cell transfers is enabled, but contamination risk increases
Solution Approach 1:
The system maintains cell cultures in a closed, sterile environment with controlled atmosphere throughout the entire process. All operations including media changes, cell transfers, and reagent additions are performed through sealed ports without opening the culture vessels, eliminating contamination risks associated with repeated opening and closing of flasks.
Solution Approach 2:
The system uses automated liquid handling robots and sealed transfer systems as intermediaries to perform all operations. These intermediaries enable media changes, cell transfers, and reagent additions without direct manual access to open vessels, maintaining sterility while achieving operational flexibility through automated interfaces.
3Ease of manufacture
If conventional manual protocols are used for T cell therapy production, then current equipment and facilities can be utilized, but current good manufacturing practices (cGMP) compliance is not achieved
Solution Approach 1:
The system replaces manual mechanical operations with automated control systems. Automated liquid handlers, pumps, and sensors perform all cell culture operations with precise control and documentation, replacing manual techniques that cannot meet cGMP requirements for traceability, consistency, and quality control.
Solution Approach 2:
The system incorporates continuous monitoring and feedback control to maintain culture conditions within specified parameters. Sensors track pH, temperature, oxygen levels, and cell density in real-time, with automated adjustments ensuring consistent, reproducible results that meet cGMP standards for process control and quality assurance.
4Manufacturing precision
If multiple manual steps are required for T cell culture protocols, then detailed process control is possible, but time consumption and user error opportunities increase
Solution Approach 1:
The system performs multiple operations continuously without interruption. The automated liquid handling system executes media changes, reagent additions, and cell transfers in continuous sequences, eliminating the time losses associated with manual setup and teardown between operations while maintaining precise control through automated programming.
Solution Approach 2:
The system prepares and pre-configures all reagents, media, and culture conditions before cell culture begins. Protocols are pre-programmed with precise timing and sequencing, allowing the system to execute complex multi-step procedures automatically without real-time manual intervention, reducing both time consumption and opportunities for user error.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The systems provide efficient, scalable, and safe production of T cells, meeting cGMP requirements while reducing costs and simplifying the process, suitable for both pre-clinical research and clinical manufacturing.
Implementation Method 1
The cell culture chamber is made of a gas-impermeable material, such as polystyrene, which is a material to which cells will adhere
Implementation Method 2
The various chambers and vessels are connectable via sterile tube welding, so that the system can remain closed throughout use
Data Source
AI summary
Cell culture systems and methods provide improved immunotherapeutic product manufacturing with greater scalability, flexibility, and automation. Cell culture systems are configured with interchangeable cartridges, allowing versatility and scalability. Systems are configured to have multiple connected cell culture chambers, which allows parallel processing of different types of cells. Gas-impermeable cell culture chambers and methods for generating cells in closed systems prevent contamination and user error. Methods for recycling cell culture medium provide additional efficiencies.